Vai offline con l'app Player FM !
On Target with Dr Akila Viswanathan - Personalized Dose for Seminars in Radiation Oncology
Manage episode 440385660 series 2310018
In this On Target podcast, Dr Akila Viswanathan, Director of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins Kimmel Cancer Center, speaks with Dr. Deborah Citrin from the National Cancer Institute’s Center for Cancer Research and Dr. Zachary Morris from the University of Wisconsin School of Medicine and Public Health for an issue of Seminars in Radiation Oncology focusing on personalized dose.
The discussion explores advancements in radiation therapy, including how modern technology and biology are being used to tailor radiotherapy doses to individual patients. Dr Citrin highlights the potential of integrating genomics, imaging, and biomarkers to achieve personalized treatment, while Dr Morris examines disease-specific biomarkers and their application in clinical practice.
This episode covers key topics such as using gene expression signatures to predict radiation response, leveraging imaging for adaptive therapy, and how molecular markers are helping to refine treatment decisions. They also explore the promise of circulating tumor DNA as a tool for guiding radiation dosage and the complexities of combining radiation with immunotherapy.
120 episodi
Manage episode 440385660 series 2310018
In this On Target podcast, Dr Akila Viswanathan, Director of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins Kimmel Cancer Center, speaks with Dr. Deborah Citrin from the National Cancer Institute’s Center for Cancer Research and Dr. Zachary Morris from the University of Wisconsin School of Medicine and Public Health for an issue of Seminars in Radiation Oncology focusing on personalized dose.
The discussion explores advancements in radiation therapy, including how modern technology and biology are being used to tailor radiotherapy doses to individual patients. Dr Citrin highlights the potential of integrating genomics, imaging, and biomarkers to achieve personalized treatment, while Dr Morris examines disease-specific biomarkers and their application in clinical practice.
This episode covers key topics such as using gene expression signatures to predict radiation response, leveraging imaging for adaptive therapy, and how molecular markers are helping to refine treatment decisions. They also explore the promise of circulating tumor DNA as a tool for guiding radiation dosage and the complexities of combining radiation with immunotherapy.
120 episodi
Tutti gli episodi
×1 On Target with Dr Akila Viswanathan - Spatially Fractionated and FLASH Radiotherapy for Seminars in Radiation Oncology 22:11
1 Cancer Matters with Dr Bill Nelson - FDA Approval of a Drug Targeting a Brain Cancer Mutation 13:17
1 On Target with Dr Akila Viswanathan - MR Guided Radiation Therapy for Seminars in Radiation Oncology 24:36
1 On Target with Dr Akila Viswanathan - The Science and Management of Soft Tissue Sarcomas for Seminars in Radiation Oncology 17:07
Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.